TIDMIBT RNS Number : 9804V Intl. Biotechnology Trust PLC 03 November 2014 INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the "Company") Annual Financial Report Announcement of Audited Results for the year ended 31 August 2014 The following ... ADVFN UK, 1 month ago
Annual Financial Report - Replacement - TrustNet, 1 month ago
Annual Financial Report - TrustNet, 1 month ago
1 images for "biotechnology regulatory authority of india b"
Regulatory Story Polar Cap Gbl Healthcare Growth&IT - PCGH Released 07:00 16-Dec-2014 RNS Number : 8320Z Polar Cap Gbl Healthcare Growth&IT 16 December 2014 POLAR CAPITAL GLOBAL HEALTHCARE GROWTH AND INCOME TRUST PLC ANNUAL RESULTS ANNOUNCEMENT ...London Stock Exchange, 4 days ago
Summary Gilead Sciences is an American biotechnology company with a distinguished product pipe line that, in recent years, has enjoyed high revenue, earnings-per-share, and net income growth. In Q3 2014, Gilead grew year-over-year in a multitude ...Seeking Alpha, 3 weeks ago
Regulatory Story Scottish Mortgage Inv Tst PLC - SMT Released 07:00 07-Nov-2014 RNS Number : 4075W Scottish Mortgage Inv Tst PLC 07 November 2014 RNS Announcement Scottish Mortgage Investment Trust PLC Results for the half-year to 30 September ...London Stock Exchange, 1 month ago
) - (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products today provided a business update and announced financial resultsfor the three and nine months ended September 30, 2014. ...Tamar Securities, 1 month ago
More from: , BioMedReports...and 1 other sources
GENEREX BIOTECHNOLOGY CORP - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
As used herein, the terms the "Company," "Generex," "we," "us," or "our" refer to Generex Biotechnology Corporation, a Delaware corporation. The following discussion and analysis by management provides information with respect to our financial ...Pharmacy Choice, 1 week ago EPIRUS BIOPHARMACEUTICALS, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations. Pharmacy Choice, 1 month ago NOVAVAX INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations TMC Net, 1 month ago IMS HEALTH HOLDINGS, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations TMC Net, 1 month ago
Jeddah Diwaniyah presents a Certificate of Appreciation to Consul General of India B.S. Mubarak for giving a presentation on "Make in India." — Courtesy photos Syed Baqer Ali JEDDAH — Indian Consul General BS Mubarak showcased the ...Saudi Gazette, 2 weeks ago
By Jason Napodano, CFA & David Bautz, PhD NASDAQ:EPRS Epirus Biopharmaceuticals ( EPRS ) is a biopharma company focused on developing, manufacturing, and commercializing biosimilar therapeutics in various jurisdictions worldwide. The company ...Yahoo! Finance, 1 day ago
This report analyzes the worldwide markets for in US$ Million by the following Testing Types: Pathogens Testing, Pesticide Testing, GMO Testing, and Other Testing. The End-Use markets also analyzed in the report include Processed Food, Dairy, Meat, ...Global Information Inc, 4 days ago
/PRNewswire/ -- Prospects for Leading Companies Sponsored by: Report Details Infusion pumps - new study showing you trends, R&D progress, and predicted revenues Where is the infusion pumps market heading? Visiongain's brand new report shows ...TickerTech.com, 1 week ago
on your WebpageAdd Widget >Get your members hooked!